Literature DB >> 16751356

Cutting edge: allogeneic CD4+CD25+Foxp3+ T regulatory cells suppress autoimmunity while establishing transplantation tolerance.

Dennis Adeegbe1, Allison L Bayer, Robert B Levy, Thomas R Malek.   

Abstract

An important unresolved question with regard to T regulatory (Treg) cell specificity and suppressive activity is whether allogeneic Treg cells inhibit self-reactive T cells. In the present study, this issue was addressed using IL-2Rbeta-deficient mice that develop rapid lethal autoimmunity due to impaired production of Treg cells. We show that adoptive transfer of completely MHC-mismatched Treg cells into IL-2Rbeta(-/-) mice resulted in life-long engraftment of the donor cells, which exhibited skewed reactivity toward host alloantigens, and prevented autoimmunity. Thus, Treg cells that underwent thymic selection by peptide/MHC class II complexes distinct from those recognized by autoreactive T cells, still effectively suppress autoimmunity. Remarkably, when such animals were skin grafted, they exhibited dominant tolerance to those grafts bearing MHC molecules that were shared with donor Treg cells. Collectively, these data demonstrate that effective engraftment by allogeneic Treg cells controls autoimmunity and results in permissive conditions for long-term acceptance of allografts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16751356     DOI: 10.4049/jimmunol.176.12.7149

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  The Lower Limit of Regulatory CD4+ Foxp3+ TCRβ Repertoire Diversity Required To Control Autoimmunity.

Authors:  Aixin Yu; Michael J Dee; Dennis Adeegbe; Connor J Dwyer; Norman H Altman; Thomas R Malek
Journal:  J Immunol       Date:  2017-03-06       Impact factor: 5.422

2.  Regulatory T-cell subset analysis and profile of interleukin (IL)-10, IL-17 and interferon-gamma cytokine-producing cells in kidney allograft recipients with donor cells infusion.

Authors:  Moslem Ranjbar; Ghasem Solgi; Mousa Mohammadnia; Behrouz Nikbin; Gholamreza Pourmand; Bita Ansaripour; Aliakbar Amirzargar
Journal:  Clin Exp Nephrol       Date:  2012-08       Impact factor: 2.801

3.  Spontaneous renal allograft acceptance associated with "regulatory" dendritic cells and IDO.

Authors:  Charles H Cook; Alice A Bickerstaff; Jiao-Jing Wang; Tibor Nadasdy; Patricia Della Pelle; Robert B Colvin; Charles G Orosz
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

4.  Adoptive T Regulatory Cell Therapy for Tolerance Induction.

Authors:  Cecilia Cabello-Kindelan; Shane Mackey; Allison L Bayer
Journal:  Curr Transplant Rep       Date:  2015-06-01

5.  Allogeneic T regulatory cell-mediated transplantation tolerance in adoptive therapy depends on dominant peripheral suppression and central tolerance.

Authors:  Dennis Adeegbe; Robert B Levy; Thomas R Malek
Journal:  Blood       Date:  2009-12-29       Impact factor: 22.113

6.  Induction of antigen-specific immune tolerance by TGF-beta-induced CD4+Foxp3+ regulatory T cells.

Authors:  Huimin Fan; Julie Wang; Xiaohui Zhou; Zhongmin Liu; Song Guo Zheng
Journal:  Int J Clin Exp Med       Date:  2009-08-25

Review 7.  Role of immune-regulatory cells in skin pathology.

Authors:  Dan Ilkovitch
Journal:  J Leukoc Biol       Date:  2010-07-13       Impact factor: 4.962

8.  Altered frequency and phenotype of CD4+ forkhead box protein 3+ T cells and its association with autoantibody production in human immunodeficiency virus-infected paediatric patients.

Authors:  R J Argüello; J Balbaryski; G Barboni; M Candi; E Gaddi; S Laucella
Journal:  Clin Exp Immunol       Date:  2012-05       Impact factor: 4.330

Review 9.  The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation.

Authors:  Allison L Bayer; Alberto Pugliese; Thomas R Malek
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

10.  CD4(+) CD25(+) Foxp3(+) T regulatory cells with limited TCR diversity in control of autoimmunity.

Authors:  Dennis Adeegbe; Takaji Matsutani; Jing Yang; Norman H Altman; Thomas R Malek
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.